BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 31332492)

  • 1. Impact of Timeliness of Surgical Treatment on the Outcomes of Patients with Non-metastatic Non-small Cell Lung Cancer: Findings From the PLCO Trial.
    Abdel-Rahman O
    World J Surg; 2019 Nov; 43(11):2927-2933. PubMed ID: 31332492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sublobar resection is equivalent to lobectomy for clinical stage 1A lung cancer in solid nodules.
    Altorki NK; Yip R; Hanaoka T; Bauer T; Aye R; Kohman L; Sheppard B; Thurer R; Andaz S; Smith M; Mayfield W; Grannis F; Korst R; Pass H; Straznicka M; Flores R; Henschke CI;
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):754-62; Discussion 762-4. PubMed ID: 24280722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of current versus former smoking status on the outcomes of non-metastatic non-small cell lung cancer treated with upfront surgery; findings from the National Lung Screening Trial.
    Abdel-Rahman O
    Expert Rev Respir Med; 2019 Jun; 13(6):585-591. PubMed ID: 31055993
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of primary tumor resection on the survival of patients with stage IV extrathoracic metastatic non-small cell lung cancer: A population-based study.
    Sun Z; Sui X; Yang F; Wang J
    Lung Cancer; 2019 Mar; 129():98-106. PubMed ID: 30545693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term survival outcomes by smoking status in surgical and nonsurgical patients with non-small cell lung cancer: comparing never smokers and current smokers.
    Meguid RA; Hooker CM; Harris J; Xu L; Westra WH; Sherwood JT; Sussman M; Cattaneo SM; Shin J; Cox S; Christensen J; Prints Y; Yuan N; Zhang J; Yang SC; Brock MV
    Chest; 2010 Sep; 138(3):500-9. PubMed ID: 20507946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer.
    Koike T; Koike T; Yoshiya K; Tsuchida M; Toyabe S
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):372-8. PubMed ID: 23870323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wedge resection verses lobectomy for stage 1 non-small-cell lung cancer.
    Warwick R; Mediratta N; Shackcloth M; Page R; McShane J; Shaw M; Poullis M
    Asian Cardiovasc Thorac Ann; 2013 Oct; 21(5):566-73. PubMed ID: 24570559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Results for Clinical Stage IA Lung Cancer: Comparing Lobectomy and Sublobar Resection.
    Subramanian M; McMurry T; Meyers BF; Puri V; Kozower BD
    Ann Thorac Surg; 2018 Aug; 106(2):375-381. PubMed ID: 29580779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical Disparities Among Patients With Stage I Lung Cancer in the National Lung Screening Trial.
    Balekian AA; Wisnivesky JP; Gould MK
    Chest; 2019 Jan; 155(1):44-52. PubMed ID: 30056040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cause-specific death after surgical resection for early-stage non-small-cell lung cancer.
    Bugge AS; Lund MB; Valberg M; Brustugun OT; Solberg S; Kongerud J
    Eur J Cardiothorac Surg; 2018 Jan; 53(1):221-227. PubMed ID: 28950311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].
    Pfannschmidt J; Muley T; Hoffmann H; Bülzebruck H; Dienemann H
    Dtsch Med Wochenschr; 2006 Nov; 131(47):2643-8. PubMed ID: 17109272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative biopsy does not affect postoperative outcomes of resectable non-small cell lung cancer.
    Taniguchi Y; Fukumoto K; Matsui H; Saito T; Murakawa T
    Gen Thorac Cardiovasc Surg; 2019 Jul; 67(7):615-623. PubMed ID: 30659509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Survival Rates After a Combination of Local Treatment and Systemic Therapy vs Systemic Therapy Alone for Treatment of Stage IV Non-Small Cell Lung Cancer.
    Uhlig J; Case MD; Blasberg JD; Boffa DJ; Chiang A; Gettinger SN; Kim HS
    JAMA Netw Open; 2019 Aug; 2(8):e199702. PubMed ID: 31433481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcomes of surgical resection for stage IV non-small-cell lung cancer: A national analysis.
    Yang CJ; Gu L; Shah SA; Yerokun BA; D'Amico TA; Hartwig MG; Berry MF
    Lung Cancer; 2018 Jan; 115():75-83. PubMed ID: 29290266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical results of metastatic spinal cord compression (MSCC) from non-small cell lung cancer (NSCLC): analysis of functional outcome, survival time, and complication.
    Park SJ; Lee CS; Chung SS
    Spine J; 2016 Mar; 16(3):322-8. PubMed ID: 26586194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pneumonectomy for Clinical Stage IIIA Non-Small Cell Lung Cancer: The Effect of Neoadjuvant Therapy.
    Broderick SR; Patel AP; Crabtree TD; Bell JM; Morgansztern D; Robinson CG; Kreisel D; Krupnick AS; Patterson GA; Meyers BF; Puri V
    Ann Thorac Surg; 2016 Feb; 101(2):451-7; discussion 457-8. PubMed ID: 26410162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathologic Upstaging in Patients Undergoing Resection for Stage I Non-Small Cell Lung Cancer: Are There Modifiable Predictors?
    Bott MJ; Patel AP; Crabtree TD; Colditz GA; Kreisel D; Krupnick AS; Patterson GA; Broderick S; Meyers BF; Puri V
    Ann Thorac Surg; 2015 Dec; 100(6):2048-53. PubMed ID: 26277562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary Resection for Second Lung Cancer After Pneumonectomy: A Population-Based Study.
    Ayub A; Rehmani SS; Al-Ayoubi AM; Raad W; Flores RM; Bhora FY
    Ann Thorac Surg; 2017 Oct; 104(4):1131-1137. PubMed ID: 28709663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thermal ablation matches sublobar resection outcomes in older patients with early-stage non-small cell lung cancer.
    Kwan SW; Mortell KE; Talenfeld AD; Brunner MC
    J Vasc Interv Radiol; 2014 Jan; 25(1):1-9.e1. PubMed ID: 24365502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Result of the 6-min walk test is an independent prognostic factor of surgically treated non-small-cell lung cancer.
    Marjanski T; Badocha M; Wnuk D; Dziedzic R; Ostrowski M; Sawicka W; Rzyman W
    Interact Cardiovasc Thorac Surg; 2019 Mar; 28(3):368-374. PubMed ID: 30203070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.